Tokyo

London

New York

Register

Sign In

EUR/USD

1.1129

-0.0010

-0.09%

GBP/USD

1.2809

-0.0016

-0.13%

USD/JPY

110.94

-0.2855

-0.26%

USD/CHF

0.9790

0.0004

0.04%

EUR/GBP

0.8689

0.0003

0.04%

USD/CAD

1.3477

0.0007

0.05%

NZD/USD

0.7043

-0.0008

-0.11%

EUR/JPY

123.46

-0.4370

-0.35%

EUR/CHF

1.0895

-0.0008

-0.07%

Cytomx Thera Cmn Stk

NASDAQ: CTMXHealthcare / Biotechnology / USA
14.31-0.20-1.38%Vol 122 5321Y Perf 34.75%
May 26th, 2017 16:00
BID14.31 ASK14.33
Open14.53 Previous Close14.51
Pre-Market- After-Trading14.31
 - -%  - -%
Target Price
25.67 
Analyst Rating
Strong Buy 1.40
Potencial %
79.39 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
—    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
—    -
Market Cap (mil)533 
Earnings Rating
Price Range Ratio 52wk %
47.71 
Earnings Date

Today's Price Range

14.2314.83

 

52wk Range

9.1020.02

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-5.67%
3 Months
-7.32%
6 Months
37.74%
1 Year
34.75%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CTMX14.31-0.2000-1.38
AAPL153.61-0.2600-0.17
GOOG971.471.93000.20
MSFT69.970.35000.50
XOM81.55-0.2000-0.24
WFC52.41-0.3700-0.70
JNJ126.92-0.6100-0.48
FB152.130.17000.11
GE27.45-0.0400-0.15
JPM85.360.01000.01
...

TickerPriceChg.%52 Week High
MNK43.285.5685.83
ULTA302.403.19310.00
KSU95.953.09100.69
NVDA141.842.59145.28
COTY19.062.4730.13
CXO131.282.21147.55
NSC122.332.14125.00
CHK5.292.128.20
GPC93.282.10105.97
NEM34.112.0346.07
HBI20.701.9728.25
ORLY248.481.90292.84
GPS22.421.8230.74
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.40
Current Ratio 4.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -32.20
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-202.70
EBITDA Margin-195.50
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.42
PS Ratios 22.52
Price to Cash Flow 12.10
Price to Free Cash Flow -29.80
Cash Flow Per Share -0.43
Price to Tangible Book7.70
Book Value per Share2.01
Enterprise Value (in ths.)385 048
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -57.03
Return on Assets (5Y Avg) -
ROA last 12 Months -28.60
Return on Capital (5Y Avg) -
ROC last 12 Months -55.72
Return on invested Capital Q -11.16
Return on invested Capital Y-16.95
Assets Turnover0.10
Receivables Turnover49.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)24 473
Revenue per Share 0.67
Revenue Growth 3 Years 82.41
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.55-0.2358.18
Q04 2016-0.45-0.3913.33
Q03 2016-0.35-0.40-14.29
Q02 2016-0.41-0.394.88
Q01 2016-0.26-0.44-69.23
Q04 2015-0.34-0.39-14.71
Q03 2015-0.25-14.26-5 604.00
----
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.3782.87Positive
9/2017 QR-0.3888.62Positive
12/2017 FY-1.28--
12/2018 FY-1.02--
Next Report Date5th May 2017
Estimated EPS Next Report-0.55
Estimates Count5
EPS Growth Next 5 Years %0.00
Volume Overview
Volume122 532
Shares Outstanding (in ths.)36 750
Trades Count692
Dollar Volume1 521 340
Avg. Volume229 631
Avg. Weekly Volume128 346
Avg. Monthly Volume165 237
Avg. Quarterly Volume290 758

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

83%17%

Bearish Bullish

80%20%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.50

There are no comments yet.

News

Plus500
x